Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers

…, EM Swisher, BY Karlan, MK Agarwal, J Higgins… - Nature, 2008 - nature.com
Ovarian carcinomas with mutations in the tumour suppressor BRCA2 are particularly
sensitive to platinum compounds 1 . However, such carcinomas ultimately develop cisplatin …

Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer

…, S Casadei, KH Coats, E Swisher, SM Stray, J Higgins… - Jama, 2006 - jamanetwork.com
ContextGenetic testing for inherited mutations in BRCA1 and BRCA2 has become integral to
the care of women with a severe family history of breast or ovarian cancer, but an unknown …

Functional Restoration of BRCA2 Protein by Secondary BRCA2 Mutations in BRCA2-Mutated Ovarian Carcinoma

…, FJ Couch, SP Langdon, K Wurz, J Higgins… - Cancer research, 2009 - AACR
Acquired platinum resistance is a serious problem in the treatment of ovarian carcinomas.
However, the mechanism of the drug resistance has not been elucidated. Here, we show …

Response to DNA damage of CHEK2 missense mutations in familial breast cancer

W Roeb, J Higgins, MC King - Human molecular genetics, 2012 - academic.oup.com
Comprehensive sequencing of tumor suppressor genes to evaluate inherited predisposition
to cancer yields many individually rare missense alleles of unknown functional and clinical …

[HTML][HTML] Five novel loci for inherited hearing loss mapped by SNP-based homozygosity profiles in Palestinian families

…, T Walsh, AA Rayyan, MK Lee, J Higgins… - European Journal of …, 2010 - nature.com
In communities with high rates of consanguinity and consequently high prevalence of recessive
phenotypes, homozygosity mapping with SNP arrays is an effective approach for gene …

[HTML][HTML] Ultra-accurate Duplex Sequencing for the assessment of pretreatment ABL1 kinase domain mutations in Ph+ ALL

…, G Garcia-Manero, R Garris, J Higgins… - Blood cancer …, 2020 - nature.com
Mutations of ABL1 are the dominant mechanism of relapse in Philadelphia chromosome-positive
acute lymphoblastic leukemia (Ph + ALL). We performed highly accurate Duplex …

[HTML][HTML] Disrupting SUMOylation enhances transcriptional function and ameliorates polyglutamine androgen receptor–mediated disease

…, HL Montie, S Mukherjee, J Higgins… - The Journal of …, 2015 - Am Soc Clin Investig
Expansion of the polyglutamine (polyQ) tract within the androgen receptor (AR) causes
neuromuscular degeneration in individuals with spinobulbar muscular atrophy (SBMA). PolyQ …

[HTML][HTML] Quantification of measurable residual disease using duplex sequencing in adults with acute myeloid leukemia

LW Dillon, J Higgins, H Nasif, M Othus, L Beppu… - …, 2024 - ncbi.nlm.nih.gov
The presence of measurable residual disease (MRD) is strongly associated with treatment
outcomes in acute myeloid leukemia (AML). Despite the correlation with clinical outcomes, …

[HTML][HTML] Interaction of the androgen receptor, ETV1, and PTEN pathways in mouse prostate varies with pathological stage and predicts cancer progression

J Higgins, M Brogley, N Palanisamy, R Mehra… - Hormones and …, 2015 - Springer
To examine the impact of common somatic mutations in prostate cancer (PCa) on androgen
receptor (AR) signaling, mouse models were designed to perturb sequentially the AR, ETV1, …

svCapture: efficient and specific detection of very low frequency structural variant junctions by error-minimized capture sequencing

TE Wilson, S Ahmed, J Higgins, JJ Salk… - NAR Genomics and …, 2023 - academic.oup.com
Error-corrected sequencing of genomic targets enriched by probe-based capture has become
a standard approach for detecting single-nucleotide variants (SNVs) and small insertion/…